当前位置: 首页 > 详情页

Endogenous cannabinoid system alterations and their role in epileptogenesis after brain injury in rat

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tian Tan Xi Li, Beijing 100050, Peoples R China; [2]Beijing Key Lab Neurostimulat, Beijing 100050, Peoples R China; [3]Beijing Jingmei Grp Gen Hosp, Beijing 102300, Peoples R China; [4]Capital Med Univ, Beijing Neurosurg Inst, Stereotact & Funct Neurosurg Lab, Beijing 100050, Peoples R China; [5]Peking Univ, Hosp Fengtai Hosp 1, Med Alliance Beijing Tian Tan Hosp, Epilepsy Ctr, Beijing 100050, Peoples R China
出处:
ISSN:

关键词: Cannabinoid CB1 receptor Post-traumatic epilepsy Epileptogenesis

摘要:
Post-traumatic epilepsy (PTE) is one of the most common complications resulting from brain injury, however, antiepileptic drugs usually fail to prevent it. Several lines of evidence have demonstrated that the endogenous cannabinoid system (ECS) plays a pivotal role during epileptogenesis in several animal models. A recent study has shown that a cannabinoid type 1 (CB1) receptor antagonist could suppress long-term neuron hyperexcitability after brain injury, but the underlying mechanisms remain largely unknown. In this study, we first analyzed the dynamic expression of different components of the ECS at various time points after brain injury in rats. Then, we conducted a 12-month-long session of behavioral monitoring after the brain injury, and based on the results, the rats were divided into a PTE group and a non-PTE group. Finally, the changes in the ECS between the two groups were compared. We found that the ECS exhibited a biphasic alteration after brain injury; the expression of the CB1 receptor and 2-arachidonoylglycerol (2-AG) in the PTE group was significantly higher than that of the non-PTE group 12 months after traumatic brain injury. Our preliminary results indicated that the ECS might be involved in post-traumatic epileptogenesis. (C) 2016 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学
JCR分区:
出版当年[2014]版:
Q3 CLINICAL NEUROLOGY
最新[2023]版:
Q3 CLINICAL NEUROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tian Tan Xi Li, Beijing 100050, Peoples R China; [2]Beijing Key Lab Neurostimulat, Beijing 100050, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tian Tan Xi Li, Beijing 100050, Peoples R China; [2]Beijing Key Lab Neurostimulat, Beijing 100050, Peoples R China; [5]Peking Univ, Hosp Fengtai Hosp 1, Med Alliance Beijing Tian Tan Hosp, Epilepsy Ctr, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17236 今日访问量:0 总访问量:925 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院